Figure 2.
Effects of LPIDs co-administration on occurrence of hypokalaemia in patients treated with YK preparations. Solid line: patients co-administered with LPIDs; dotted line: patients without LPIDs co-administration. A significant difference was observed between patients with and without LPIDs co-administration in the log-rank test (p<0.001). LPIDs, lower potassium-inducing drug; YK, Yokukansan.